FDA Authorizes Novavax COVID-19 Vaccine for Emergency Use in Ages 12-17
- Aryaman Sinha
- Aug 22, 2022
- 1 min read

The US Food and Drug Administration authorized Novavax's Covid-19 vaccine on Friday for emergency use in adolescents. It is the fourth coronavirus vaccine available in the United States and, unlike the others, it uses a protein-based technology. Awesome!
Photo Credit: Ashley Whitlatch
Comments